State Street Corp Crinetics Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 3,224,306 shares of CRNX stock, worth $91.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,224,306

Previous 3,283,275 1.8%

Holding current value

$91.8 Million

Previous $110 Million 15.79%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$25.56 - $33.76 $1.51 Million - $1.99 Million	-58,969 Reduced 1.8%	3,224,306 $92.7 Million
Q1 2025 May 15, 2025	BUY	$32.3 - $53.15 $9.45 Million - $15.5 Million	292,437 Added 9.78%	3,283,275 $110 Million
Q4 2024 Feb 14, 2025	BUY	$50.66 - $60.69 $7.72 Million - $9.25 Million	152,354 Added 5.37%	2,990,838 $153 Million
Q3 2024 Nov 14, 2024	BUY	$43.83 - $54.98 $1.12 Million - $1.41 Million	25,561 Added 0.91%	2,838,484 $145 Million
Q2 2024 Aug 14, 2024	SELL	$42.12 - $51.91 $18.6 Million - $23 Million	-442,330 Reduced 13.59%	2,812,923 $126 Million
Q1 2024 May 15, 2024	SELL	$34.76 - $46.81 $10.7 Million - $14.4 Million	-308,483 Reduced 8.66%	3,255,253 $152 Million
Q4 2023 Feb 14, 2024	BUY	$25.62 - $37.07 $18.2 Million - $26.4 Million	711,016 Added 24.92%	3,563,736 $127 Million
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $9.82 Million - $18.8 Million	614,985 Added 27.48%	2,852,720 $84.8 Million
Q2 2023 Aug 14, 2023	BUY	$15.73 - $23.6 $297,941 - $447,007	18,941 Added 0.85%	2,237,735 $40.3 Million
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $3.28 Million - $4.52 Million	214,010 Added 10.67%	2,218,794 $35.6 Million
Q4 2022 Feb 14, 2023	BUY	$15.49 - $19.05 $3.04 Million - $3.74 Million	196,119 Added 10.84%	2,004,784 $36.7 Million
Q3 2022 Nov 15, 2022	BUY	$18.11 - $22.37 $866,020 - $1.07 Million	47,820 Added 2.72%	1,808,665 $35.5 Million
Q2 2022 Aug 15, 2022	BUY	$16.49 - $27.64 $992,137 - $1.66 Million	60,166 Added 3.54%	1,760,845 $32.8 Million
Q1 2022 May 16, 2022	BUY	$17.15 - $28.31 $6.87 Million - $11.3 Million	400,305 Added 30.78%	1,700,679 $37.3 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $3.57 Million - $5.24 Million	184,515 Added 16.54%	1,300,374 $36.9 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $25.23 $9.61 Million - $14.4 Million	569,427 Added 104.21%	1,115,859 $23.5 Million
Q2 2021 Aug 16, 2021	BUY	$15.9 - $21.15 $1.17 Million - $1.56 Million	73,871 Added 15.63%	546,432 $10.3 Million
Q1 2021 May 17, 2021	SELL	$13.3 - $17.55 $109,565 - $144,576	-8,238 Reduced 1.71%	472,561 $7.22 Million
Q4 2020 Feb 16, 2021	BUY	$12.08 - $17.46 $447,249 - $646,439	37,024 Added 8.34%	480,799 $6.78 Million
Q3 2020 Nov 10, 2020	BUY	$13.62 - $17.66 $337,776 - $437,968	24,800 Added 5.92%	443,775 $6.95 Million
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $2.54 Million - $4.52 Million	194,481 Added 86.63%	418,975 $7.34 Million
Q1 2020 May 11, 2020	BUY	$11.52 - $26.46 $2.59 Million - $5.94 Million	224,494 New	224,494 $3.3 Million

Others Institutions Holding CRNX

# of Institutions

232

Shares Held

90M

Call Options Held

59.7K

Put Options Held

14.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $1.53B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Crinetics Pharmaceuticals, Inc. Transaction History